Due to its exemplary roles in SN dopamine neurons and diverse spread across the brain CaV channels can be a potential drug target for PD, also to monitor the progress of any related treatment efficacy thereby reducing the side-effects of available therapeutics, if any (Fig. 8). The gene discussed is CAV1; the disease is Parkinson disease.